Shoushtari, A. N., Friedman, C. F., Navid-Azarbaijani, P., Postow, M. A., Callahan, M. K., Momtaz, P., . . . Chapman, P. B. (2018). Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma. JAMA oncology, 4(1), 98. https://doi.org/10.1001/jamaoncol.2017.2391
Chicago-Zitierstil (17. Ausg.)Shoushtari, Alexander N., Claire F. Friedman, Pedram Navid-Azarbaijani, Michael A. Postow, Margaret K. Callahan, Parisa Momtaz, Katherine S. Panageas, Jedd D. Wolchok, und Paul B. Chapman. "Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma." JAMA Oncology 4, no. 1 (2018): 98. https://doi.org/10.1001/jamaoncol.2017.2391.
MLA-Zitierstil (9. Ausg.)Shoushtari, Alexander N., et al. "Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma." JAMA Oncology, vol. 4, no. 1, 2018, p. 98, https://doi.org/10.1001/jamaoncol.2017.2391.